ONWD — Onward Medical NV Cashflow Statement
0.000.00%
Last trade - 00:00
- €162.41m
- €134.47m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -9.89 | -13.4 | -20 | -34.2 | -33.5 |
Depreciation | |||||
Non-Cash Items | 1.85 | 2.86 | 7.17 | 14.5 | 3.46 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.658 | 0.514 | -0.348 | -0.437 | 2.66 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.16 | -9.85 | -12.9 | -19.9 | -26.7 |
Capital Expenditures | -0.103 | -0.124 | -0.173 | -2.32 | -0.417 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | 0.025 | — | — | -20 |
Sale of Business | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.103 | -0.099 | -0.173 | -2.32 | -20.4 |
Financing Cash Flow Items | — | — | — | -4.6 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.65 | 16.4 | 4.37 | 105 | -0.557 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.39 | 6.46 | -8.75 | 83.1 | -47.7 |